A Variant PfCRT Isoform Can Contribute to Plasmodium Falciparum Resistance to the First-Line Partner Drug Piperaquine

Satish K. Dhingra, Devasha Redhi, Jill M. Combrinck, Tomas Yeo, John Okombo, Philipp P. Henrich, Annie N. Cowell, Purva Gupta, Matthew L. Stegman, Jonathan M. Hoke, Roland A. Cooper, Elizabeth Winzeler, Sachel Mok, Timothy J. Egan, David A. Fidock

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalMBio
Volume8
DOIs
StatePublished - May 1 2017
Externally publishedYes

Keywords

  • Malaria
  • PfCRT
  • PLasmodium falciparum
  • Artemisinin-based combination therapies
  • Digestive vacuole
  • Genome editing
  • Heme detoxification
  • Piperaquine resistance

Disciplines

  • Biology
  • Parasitic Diseases
  • Pharmacology

Cite this